We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Woodford Patient Capital Trust Plc | LSE:WPCT | London | Ordinary Share | GB00BVG1CF25 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 33.60 | 33.55 | 33.90 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
07/1/2017 13:51 | The trust is on the way to a bigger discount in my view. It's no longer a new trust and the froth is gone. The performance to date has also been poor. Can see it going down to 50/60p myself. Its then probably a buy as I would guess that Woodford will generate a 10% return per annum here over the long-term, so should grow to £2 in 10 years. Just my thoughts! | topvest | |
07/1/2017 10:17 | Citywire has an article noting that WPCT is now at its cheapest, relative to NAV: Woodford Patient Capital Trust might be worth a look for anyone who didn’t join its £800 million record flotation in 2015. Neil Woodford’s trust has so far disappointed investors like me who leaped at the chance to back the star manager’s passion for early stage medical and technology stocks. After an early rally the stock slid back and at just under 90p is still a long way off its 100p launch price. However, the shares have rallied from a post-Brexit low of 81p, helped in part by the revival in healthcare and biotech prompted by the election of Donald Trump. Nevertheless, its share price gain has not fully reflected the advance in the net asset value of the underlying portfolio, the result being the discount has widened to 6%, close to the low reached after the EU referendum vote. It then goes on to analyse Z-scores of various trusts: | jonwig | |
07/1/2017 10:13 | I'm a bit surprised that this defunct thread is attracting more posts than its replacement. It seems a good idea, then, to resurrect it by populating the header. I'm also (see next post) looking again at an investment. Of course, there will still be posters who use the thread to pump their own wares rather than stay focussed. (warwick69, filtered, please note.) | jonwig | |
07/1/2017 09:43 | Put this back on my watch list. Good share to buy in a stock market downturn in my view when the NAV dips and the discount widens. Now is not the right time, but could be interesting in the next year or two. | topvest | |
06/1/2017 21:09 | Woodford should look at this one PHE I suggest all potential investors start to work out just how amazingly profitable this business will be£85 a ton is land fill tax pus the sites charge a gate fee can cost up to £140 a ton to go to land fil so we can easily get £85 a ton plus we can earn £60 for each mw/hr of electric and each Ton of waste should produce 1 mw/hr of electricity so just work that out £145 per ton at 100 tons thats £14,500 income per day x 350 days == £5,075,000 revenue from one 100 ton a day plantSo just start to work out the revenue per 1000 ton site it will blow your minds ?And we are valued at a fraction of potential revenueOn my calls I think we only need to convert 50 tons of waste a day to generate 100% of the current mcap in revenue every yearAnd 50 tons is small fryjust imagine the profits we can generate in time then give us a 10 PE ratio which would still be cheap and we are looking at 200 300 million pound companythis is not pie in the sky stupid dreaming this is real opportunity for the investment of a lifetimeits all about do you believe we can accomplish a sale can we bring this to an industrial site near you and generate real revenuesYOU DECIDEbut if you want to make a fortune this could be a great place to startthis is a;; of course my own opinion and in no way am i giving any adviceas they say Do Your Own Research | warwick69 | |
06/1/2017 19:22 | Disappointing 10% discount to NAV today after touching premium of 20% in August 2015 with frenetic trading. WPCT is very much different to his previous funds these are startups and early stage companies paying little or no dividends hungry for capital with unseasoned management who tend to oversell their technology, I really was surprised how quickly he invested all the funds. One presumes he has an experienced team behind him in these kind of investments. Let's hope the answer is in the name "Patient". I did sell part of my original holding which leaves me even on balance. Edit should read 10% discount to issue price after touching 20% premium. AO | a0148009 | |
06/1/2017 15:46 | He didn't have a great year last year here or with the equity income fund which underperformed. But the WEIF is still my largest holding - will have another look this time next year to see if he has lost his touch. His record over 20 years is astonishing, but there are some duff years within that. | dr biotech | |
06/1/2017 15:37 | Lol. I do notice the NAV has come up along with US biotech. | hutch_pod | |
06/1/2017 15:36 | In every 'genius' there's a moron fighting to get out. Is WPCT Woodford's inner moron? | jl9 | |
30/12/2016 17:19 | Rns released, but my mistake, sorry. 12.53% with varying lent out. 12.53%, <5M lent out. 12.53%, 5M lent out. Looks like reduced since March. | p1nkfish | |
30/12/2016 04:29 | How do you know this pinkfish ? | harveydee | |
29/12/2016 20:28 | Blackrock interest is still alive. They keep buying. | p1nkfish | |
13/12/2016 18:16 | Woodford abandons 'house of cards' US pharma stock, (Investment Week, 12th Dec 2016) Neil Woodford has said he will stop investing in beleaguered US pharmaceutical Northwest Biotherapeutics, after the value of its stock fell by nearly 90% amid a raft of problems at the firm. The manager of the £9.4bn Woodford Equity Income fund currently has a small holding in the stock in the fund, and 0.3% in his £761m Patient Capital Trust. Woodford Investment Management was the firm's largest shareholder, with a 21% stake. However, the value of his original holding in the firm has fallen from $180m to just $15m .. | bdog51 | |
01/12/2016 10:25 | Did a comparison to IPO Group going back 2 years. WPCT has been much less risky/volatile and looks a better hold. | timtom2 | |
15/11/2016 18:48 | Poss gap fill up there - assuming a rates rise doesn't dent the mkt free stock charts from uk.advfn.com | luckymouse | |
15/11/2016 16:44 | Aye, also the Director buy this PM helps as does the announcement from MTPH given the large traunch Woodford picked up at 110p (price as I type 125p)... You never know we might breach the launch price soon... | gwatson56 | |
15/11/2016 09:50 | PRTA and ALM both moving up sharply at the moment. With shares at a discount looks a good time to buy or top up IMO. | mad foetus | |
10/11/2016 13:37 | Thanks for the link n0rbie, I hadn't realised Neil had posted something already. | sareg nenn | |
10/11/2016 12:27 | Jump will be due to blog post by Neil Woodford yesterday on trump victory, bullish thoughts especially on health care holdings: EARLY THOUGHTS ON TRUMP’S VICTORY hxxps://woodfordfund | n0rbie | |
10/11/2016 08:52 | Sensible looking mercia results. | p1nkfish | |
09/11/2016 17:31 | I think one of the us states also voted not to impose a price cap on prescription drugs. PRTA now up 13% though it did lose 20% last week. | mad foetus | |
09/11/2016 15:20 | Nice little tick up for us this afternoon. I thought perhaps it was just the US election results as Netnut mentions above, but then noticed that Prothena is up over 10% at the time of writing this. I'm at work so can't check but anyone know the reason for the jump? | sareg nenn | |
09/11/2016 08:38 | No screwing down American pharmaceuticals now by Clinton then? That's got to be a good thing? | netnut | |
07/11/2016 16:47 | Interesting point here on the chart if it does an IHS - discount has bounced | luckymouse | |
01/11/2016 09:49 | PRTA has taken a reaming stateside in the last couple of days. We could do with one of the investments roaring away imo | mad foetus |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions